JOHN GRIMES: Open Payments
NPI 1174956908 · GUNTERSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,255 in 100 payments from 13 companies in 2025. Trend: 2023 $966 · 2024 $1,573 · 2025 $2,255
Food & beverage: $2,255
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 28 | $493 |
| AstraZeneca Pharmaceuticals LP | 13 | $338 |
| Regeneron Healthcare Solutions, Inc. | 8 | $270 |
| Grifols USA, LLC | 10 | $256 |
| GENZYME CORPORATION | 10 | $241 |
| Axsome Therapeutics, Inc. | 14 | $226 |
| HARMONY BIOSCIENCES LLC | 3 | $116 |
| Amgen Inc. | 5 | $92 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $84 |
| Inspire Medical Systems, Inc. | 2 | $59 |
Products named: DUPIXENT, TRELEGY ELLIPTA, AIRSUPRA, Prolastin-C Liquid, Sunosi, NUCALA, WAKIX, TEZSPIRE.
Industry payments across AL — which companies pay providers there.
